- Rare Disease News
- This event has passed.
The FSHD Society’s FSHD University: The FORTITUDE Trial
February 14, 2023 @ 1:00 pm - 2:00 pm
FSHD University: The FORTITUDE Trial
February 14, 2023
Avidity Biosciences has announced its plans to launch FORTITUDE, a Phase 1 / 2 clinical trial in FSHD of the novel compound AOC 1020. This will be the first human trial of an FSHD disease-modifying drug based on an siRNA targeting DUX4 mRNA. We’ll learn more about how the drug works, the design of the trial, and where and when patients can expect to enroll in it.